Business UpdateMay 12, 2026, 08:33 AM
Lexicon Pharmaceuticals to Present at H.C. Wainwright BioConnect Conference
AI Summary
Lexicon Pharmaceuticals, Inc. announced that its management will participate in a fireside chat at the 4th Annual H.C. Wainwright BioConnect Investor Conference. The event is scheduled for May 19, 2026, at the Nasdaq World Headquarters in New York City. A live webcast and replay of the presentation will be accessible through the company's investor relations website. Lexicon is a biopharmaceutical company focused on developing medicines for conditions such as neuropathic pain, hypertrophic cardiomyopathy, obesity, and metabolic disorders.
Key Highlights
- Lexicon Pharmaceuticals management to participate in the 4th Annual H.C. Wainwright BioConnect Investor Conference.
- Fireside chat scheduled for May 19, 2026.
- Conference to be held at the Nasdaq World Headquarters in New York City.
- Live webcast and replay will be available on the company's investor relations website.
- Lexicon's pipeline includes drug candidates for neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity, and metabolic disorders.
Price Impact
More from LXRX